Chemotherapy, Cisplatin, Doxorubin, Endometrial carcinoma, Phase III, Randomised clinical trial
dx.doi.org/10.1093/annonc/mdg112, hdl.handle.net/1765/66299
Annals of Oncology
Department of Gynaecology & Obstetrics

Aapro, M, van Wijk, F, Bolis, G, Chevallier, P, van der Burg, M.E.L, Poveda, A, … Vermorken, J.B. (2003). Doxurubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Annals of Oncology, 14(3), 441–448. doi:10.1093/annonc/mdg112